A new analysis of 97 patients found 84.1% experienced a clinically significant reduction in tinnitus symptoms with Lenire as measured by the Tinnitus Handicap Inventory.
New over-the-counter hearing aids and smart glasses with advanced audio features were showcased by multiple companies at CES 2026 in Las Vegas.
Starkey has received two honors from the 2026 BIG Innovation Awards presented by the Business Intelligence Group.
The Phase 2 PROHEAR trial is evaluating ACOU085 (Bimokalner) for its efficacy in protecting hearing during chemotherapy.
A new hearing test measures how a patient’s pupils involuntarily change size in response to sound.
The new capabilities are designed to automate clinical documentation and fit naturally into existing audiology workflows.
